A better way to build neurodivergent research cohorts
Relatix Bio helps clinicians, researchers, and health innovators reach privacy-sensitive, deeply characterised participant communities with stronger engagement, better retention, and more meaningful longitudinal insight.
We are not a recruitment marketplace. We build precision cohorts across neurodiversity and chronic mental health conditions, helping partners engage the right participants for validation, comparison studies, product development, responder-pattern discovery, and real-world insight, as long as the opportunity brings value to participants.
Three reasons organisations choose Relatix Bio
The strongest advantages appear early: broader cohort access, better engagement quality, and deeper follow-up insight.
Privacy-first participation
We do not collect identifying personal data such as names, addresses, or dates of birth. That helps partners reach privacy-sensitive people who are often absent from conventional pipelines.
Why it matters: you access people traditional systems often miss, including those who are undiagnosed, not in mental health care, or cautious about formal pathways.
Participant-directed engagement
Relatix Bio introduces opportunities to participant communities rather than pushing people directly into studies. Participation starts with choice, which improves trust and makes engagement patterns visible from the outset.
Why it matters: stronger trust leads to better retention and clearer interpretation.
Longitudinal cohort relationships
Participants remain reachable over time, enabling follow-up engagement, future pilots, and a better view of how interventions perform beyond one-off validation.
Why it matters: you gain deeper insight, not just short-term recruitment.
Privacy-first participation means access to people traditional pipelines miss
Many people living with neurodevelopmental and neurocognitive differences remain underdiagnosed, underserved, or reluctant to engage through conventional research or psychiatric systems. Privacy-preserving participation allows those perspectives to be included safely.
That matters because underrepresented groups often carry the exact insight partners need when they are trying to understand responder patterns, engagement barriers, or real-world usability.
What this changes for partners
A better participation model creates better study conditions
These advantages are not abstract. They improve who you reach, how people stay engaged, and the quality of the insight you take away.
Participant-directed engagement
People choose whether to take part and can share what influenced their decision, helping partners understand engagement quality before the study even begins.
Support-network involvement
Where appropriate, carers and support networks help participants remain engaged, improving adherence and making results more reflective of real-world use.
Evidence-guided collaboration
Relatix Bio works with credible interventions or clearly framed exploratory research, protecting trust with participants and improving confidence for research partners.
Longitudinal follow-up
Because relationships continue over time, partners can revisit cohorts, observe change, and generate follow-up insight that standard recruitment vendors rarely support.
Supported communities, not anonymous recruits
Participants remain connected through Relatix Health, which provides free lifelong resources, community insight, and opportunities to contribute to responsible innovation.
This gives partners access to communities that are supported over time, not one-off transactional recruits. It also creates a channel for ideas, high-quality business insight, and grounded participant feedback that can shape better interventions and better decisions.
Ready to talk?
If you want a stronger participation model, let’s discuss your study, pilot, or validation programme
Relatix Bio is built for organisations that need better cohort access, stronger engagement, and more meaningful longitudinal insight.